{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:21:04Z","timestamp":1790374864667,"version":"4.1.0"},"reference-count":138,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":8,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010828","name":"International Psychogeriatric Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010828","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","intpsychogeriatrics.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Psychogeriatrics"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.inpsyc.2026.100240","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T21:45:46Z","timestamp":1784238346000},"page":"100240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Apathy in persons with neurocognitive disorders: Moving the field forward"],"prefix":"10.1016","author":[{"given":"Jennifer R.","family":"Gatchel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masud","family":"Husain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Brodaty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9888-008X","authenticated-orcid":false,"given":"Amer M.","family":"Burhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4490-4485","authenticated-orcid":false,"given":"Valeria","family":"Manera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanneke","family":"Nijsten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2318-715X","authenticated-orcid":false,"given":"Carolyn W.","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4759-8973","authenticated-orcid":false,"given":"Maria Paula","family":"Gastiazoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista L.","family":"Lanct\u00f4t","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.inpsyc.2026.100240_bib1","doi-asserted-by":"crossref","DOI":"10.1002\/alz.12358","article-title":"Diagnostic criteria for apathy in neurocognitive disorders","volume":"17","author":"Miller","year":"2021","journal-title":"Alzheimers Dement"},{"issue":"2","key":"10.1016\/j.inpsyc.2026.100240_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/gps.5882","article-title":"Distinguishing apathy from depression: a review differentiating the behavioral, neuroanatomic, and treatment-related aspects of apathy from depression in neurocognitive disorders","volume":"38","author":"Lanct\u00f4t","year":"2023","journal-title":"Int J Geriatr Psychiatry"},{"issue":"1","key":"10.1016\/j.inpsyc.2026.100240_bib3","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41398-022-02292-3","article-title":"The neurobiology of apathy in depression and neurocognitive impairment in older adults: a review of epidemiological, clinical, neuropsychological and biological research","volume":"12","author":"Steffens","year":"2022","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.inpsyc.2026.100240_bib4","unstructured":"Alzheimer\u2019s Society, \u2018Apathy in dementia\u2019. [Online]. Available: https:\/\/www.alzheimers.org.uk\/about-dementia\/symptoms-and-diagnosis\/apathy-dementia."},{"issue":"1","key":"10.1016\/j.inpsyc.2026.100240_bib5","article-title":"Prevalent, persistent, and impairing: longitudinal course and impact of apathy in Alzheimer\u2019s disease","volume":"13","author":"Grossman","year":"2021","journal-title":"Alzheimers Dement Diagn Assess Dis Monit"},{"issue":"1","key":"10.1016\/j.inpsyc.2026.100240_bib6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1136\/jnnp.2005.069575","article-title":"A prospective longitudinal study of apathy in Alzheimer\u2019s disease","volume":"77","author":"Starkstein","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.inpsyc.2026.100240_bib7","article-title":"Understanding the role of neuropsychiatric symptoms in functional decline in Alzheimer\u2019s disease","author":"Zhu","year":"2025","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"9","key":"10.1016\/j.inpsyc.2026.100240_bib8","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1017\/S1041610220001118","article-title":"A systematic review of the prevalence of depression, anxiety, and apathy in frontotemporal dementia, atypical and young-onset Alzheimer\u2019s disease, and inherited dementia","volume":"35","author":"Collins","year":"2023","journal-title":"Int Psychogeriatr"},{"issue":"8","key":"10.1016\/j.inpsyc.2026.100240_bib9","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/s41583-018-0029-9","article-title":"Neuroscience of apathy and anhedonia: a transdiagnostic approach","volume":"19","author":"Husain","year":"2018","journal-title":"Nat Rev Neurosci"},{"issue":"8","key":"10.1016\/j.inpsyc.2026.100240_bib10","article-title":"\u2018Predictive and monitoring value of blood-based biomarkers for apathy treatment in Alzheimer\u2019s disease\u2019","volume":"20","author":"Lanct\u00f4t","year":"2025","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.inpsyc.2026.100240_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.jalz.2016.05.008","article-title":"Apathy associated with neurocognitive disorders: recent progress and future directions","volume":"13","author":"Lanct\u00f4t","year":"2017","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.inpsyc.2026.100240_bib12","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.eurpsy.2018.07.008","article-title":"Is it time to revise the diagnostic criteria for apathy in brain disorders? The 2018 international consensus group","volume":"54","author":"Robert","year":"2018","journal-title":"Eur Psychiatry"},{"issue":"5","key":"10.1016\/j.inpsyc.2026.100240_bib13","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1017\/S1041610209991402","article-title":"Apathy and cognitive and functional decline in community-dwelling older adults: results from the Baltimore ECA longitudinal study","volume":"22","author":"Clarke","year":"2010","journal-title":"Int Psychogeriatr"},{"issue":"4","key":"10.1016\/j.inpsyc.2026.100240_bib14","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jagp.2020.07.011","article-title":"The role of neuropsychiatric symptoms in research diagnostic criteria for neurodegenerative diseases","volume":"29","author":"Cummings","year":"2021","journal-title":"Am J Geriatr Psychiatry J Am Assoc Geriatr Psychiatry"},{"issue":"4","key":"10.1016\/j.inpsyc.2026.100240_bib15","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jagp.2018.12.013","article-title":"Why do they just sit? Apathy as a core symptom of alzheimer disease","volume":"27","author":"Zhu","year":"2019","journal-title":"Am J Geriatr Psychiatry J Am Assoc Geriatr Psychiatry"},{"key":"10.1016\/j.inpsyc.2026.100240_bib16","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.neuropsychologia.2017.07.003","article-title":"The anatomy of apathy: a neurocognitive framework for amotivated behaviour","volume":"118","author":"Le Heron","year":"2018","journal-title":"Neuropsychologia"},{"issue":"1","key":"10.1016\/j.inpsyc.2026.100240_bib17","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/0891988716678684","article-title":"Pharmacological and nonpharmacological treatment for apathy in Alzheimer disease: a systematic review across modalities","volume":"30","author":"Theleritis","year":"2017","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"6","key":"10.1016\/j.inpsyc.2026.100240_bib18","doi-asserted-by":"crossref","DOI":"10.1177\/00048674221114597","article-title":"Distinguishing apathy and depression in dementia: a longitudinal study","volume":"57","author":"Connors","year":"2023","journal-title":"Aust N Z J Psychiatry"},{"issue":"11","key":"10.1016\/j.inpsyc.2026.100240_bib19","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1017\/S1041610222001089","article-title":"Apathy and depression in mild cognitive impairment: distinct longitudinal trajectories and clinical outcomes","volume":"35","author":"Connors","year":"2023","journal-title":"Int Psychogeriatr"},{"issue":"3","key":"10.1016\/j.inpsyc.2026.100240_bib20","article-title":"Apathy and health-related quality of life in nursing home residents","volume":"28","author":"Nijsten","year":"2019","journal-title":"Qual Life Res Int J Qual Life Asp Treat Care Rehabil"},{"key":"10.1016\/j.inpsyc.2026.100240_bib21","doi-asserted-by":"crossref","DOI":"10.1155\/bn\/3788122","article-title":"Apathy in neuropsychiatric disorders: clinical characteristics, neurobiological mechanisms, and therapeutic strategies","volume":"2025","author":"Totuk","year":"2025","journal-title":"Behav Neurol"},{"issue":"1","key":"10.1016\/j.inpsyc.2026.100240_bib22","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/jnp.12262","article-title":"Assessment of apathy in neurological patients using the Apathy Motivation Index caregiver version","volume":"16","author":"Klar","year":"2022","journal-title":"J Neuropsychol"},{"issue":"1","key":"10.1016\/j.inpsyc.2026.100240_bib23","article-title":"Pseudodementia, pseudo-pseudodementia, and pseudodepression","volume":"12","author":"Brodaty","year":"2020","journal-title":"Alzheimers Dement Amst Neth"},{"issue":"2","key":"10.1016\/j.inpsyc.2026.100240_bib24","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0165-1781(91)90040-V","article-title":"Reliability and validity of the Apathy Evaluation Scale","volume":"38","author":"Marin","year":"1991","journal-title":"Psychiatry Res"},{"issue":"5","key":"10.1016\/j.inpsyc.2026.100240_bib25","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1136\/jnnp.2005.075929","article-title":"The Lille apathy rating scale (LARS), a new instrument for detecting and quantifying apathy: validation in Parkinson\u2019s disease","volume":"77","author":"Sockeel","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"10.1016\/j.inpsyc.2026.100240_bib26","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1136\/jnnp.2007.136895","article-title":"The nosological position of apathy in clinical practice","volume":"79","author":"Starkstein","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"10.1016\/j.inpsyc.2026.100240_bib27","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/gps.755","article-title":"The apathy inventory: assessment of apathy and awareness in Alzheimer\u2019s disease, Parkinson\u2019s disease and mild cognitive impairment","volume":"17","author":"Robert","year":"2002","journal-title":"Int J Geriatr Psychiatry"},{"issue":"2","key":"10.1016\/j.inpsyc.2026.100240_bib28","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1176\/jnp.4.2.134","article-title":"Reliability, validity, and clinical correlates of apathy in Parkinson\u2019s disease","volume":"4","author":"Starkstein","year":"1992","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"12","key":"10.1016\/j.inpsyc.2026.100240_bib29","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1212\/WNL.44.12.2308","article-title":"The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia","volume":"44","author":"Cummings","year":"1994","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.inpsyc.2026.100240_bib30","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1017\/S1041610210000876","article-title":"The Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity of a revised assessment of neuropsychiatric symptoms in dementia","volume":"22","author":"de Medeiros","year":"2010","journal-title":"Int Psychogeriatr"},{"issue":"3","key":"10.1016\/j.inpsyc.2026.100240_bib31","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.psychres.2014.06.010","article-title":"Developing a new apathy measurement scale: Dimensional Apathy Scale","volume":"219","author":"Radakovic","year":"2014","journal-title":"Psychiatry Res"},{"issue":"1","key":"10.1016\/j.inpsyc.2026.100240_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169938","article-title":"Distinct Subtypes of Apathy Revealed by the Apathy Motivation Index","volume":"12","author":"Ang","year":"2017","journal-title":"PloS One"},{"issue":"7","key":"10.1016\/j.inpsyc.2026.100240_bib33","doi-asserted-by":"crossref","DOI":"10.1093\/cercor\/bhj043","article-title":"Apathy and the functional anatomy of the prefrontal cortex\u2013basal ganglia circuits","volume":"16","author":"Levy","year":"2006","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.inpsyc.2026.100240_bib34","series-title":"The neuropsychology of emotion, in Series in affective science.","first-page":"340","article-title":"Differentiation of states and causes of apathy","author":"Stuss","year":"2000"},{"issue":"1","key":"10.1016\/j.inpsyc.2026.100240_bib35","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1176\/jnp.17.1.7","article-title":"Apathy: why care?","volume":"17","author":"van Reekum","year":"2005","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"2","key":"10.1016\/j.inpsyc.2026.100240_bib36","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jagp.2013.01.079","article-title":"A novel rating scale for the measurement of apathy in institutionalized persons with dementia: the APADEM-NH","volume":"23","author":"Ag\u00fcera-Ortiz","year":"2015","journal-title":"Am J Geriatr Psychiatry J Am Assoc Geriatr Psychiatry"},{"issue":"3","key":"10.1016\/j.inpsyc.2026.100240_bib37","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/107319119900600307","article-title":"Assessing Frontal Lobe Behavioral Syndromes with the Frontal Lobe Personality Scale","volume":"6","author":"Grace","year":"1999","journal-title":"Assessment"},{"issue":"3","key":"10.1016\/j.inpsyc.2026.100240_bib38","first-page":"176","article-title":"An informant-based assessment of apathy in Alzheimer disease\u2019","volume":"15","author":"Strauss","year":"2002","journal-title":"Neuropsychiatry Neuropsychol Behav Neurol"},{"issue":"5","key":"10.1016\/j.inpsyc.2026.100240_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.inpsyc.2025.100074","article-title":"Mapping of validated apathy scales onto the apathy diagnostic criteria for neurocognitive disorders","volume":"37","author":"Sankhe","year":"2025","journal-title":"Int Psychogeriatr"},{"issue":"3","key":"10.1016\/j.inpsyc.2026.100240_bib40","doi-asserted-by":"crossref","first-page":"fcaf235","DOI":"10.1093\/braincomms\/fcaf235","article-title":"Self- versus caregiver-reported apathy across neurological disorders","volume":"7","author":"Zhao","year":"2025","journal-title":"Brain Commun"},{"issue":"1","key":"10.1016\/j.inpsyc.2026.100240_bib41","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jagp.2020.05.020","article-title":"Measuring Apathy in Alzheimer\u2019s Disease in the Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): A Comparison of Instruments","volume":"29","author":"Lanct\u00f4t","year":"2021","journal-title":"Am J Geriatr Psychiatry J Am Assoc Geriatr Psychiatry"},{"key":"10.1016\/j.inpsyc.2026.100240_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2024.103924","article-title":"Development and validation of the geriatric apathy scale: Examining multi-dimensional apathy profiles in a neurodegenerative population with cultural considerations","volume":"93","author":"Yi","year":"2024","journal-title":"Asian J Psychiatry"},{"key":"10.1016\/j.inpsyc.2026.100240_bib43","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.neubiorev.2016.08.012","article-title":"Neural correlates of apathy in patients with neurodegenerative disorders, acquired brain injury, and psychiatric disorders","volume":"69","author":"Kos","year":"2016","journal-title":"Neurosci Biobehav Rev"},{"issue":"10","key":"10.1016\/j.inpsyc.2026.100240_bib44","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s11910-017-0788-0","article-title":"Imaging the etiology of apathy, anxiety, and depression in parkinson\u2019s disease: implication for treatment","volume":"17","author":"Thobois","year":"2017","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"6","key":"10.1016\/j.inpsyc.2026.100240_bib45","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/ene.13002","article-title":"Depression, anxiety, and apathy in Parkinson\u2019s disease: insights from neuroimaging studies","volume":"23","author":"Wen","year":"2016","journal-title":"Eur J Neurol"},{"issue":"4","key":"10.1016\/j.inpsyc.2026.100240_bib46","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/brain\/awab013","article-title":"Apathy in small vessel cerebrovascular disease is associated with deficits in effort-based decision making","volume":"144","author":"Saleh","year":"2021","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.inpsyc.2026.100240_bib47","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s11682-017-9764-1","article-title":"Imaging behavioural complications of Parkinson\u2019s disease","volume":"13","author":"Valli","year":"2019","journal-title":"Brain Imaging Behav"},{"issue":"S1","key":"10.1016\/j.inpsyc.2026.100240_bib48","doi-asserted-by":"crossref","first-page":"S818","DOI":"10.1192\/j.eurpsy.2025.1664","article-title":"Apathy, Beta-amyloid Burden and Cognitive Decline in Parkinson\u2019s Disease Patients","volume":"68","author":"Fern\u00e1ndez-Fern\u00e1ndez","year":"2025","journal-title":"Eur Psychiatry"},{"key":"10.1016\/j.inpsyc.2026.100240_bib49","article-title":"medRxiv","author":"Kang","year":"2024","journal-title":"Apathy Affect Symptoms Assoc Elev Alzheimer\u2019S Dis Biomark"},{"issue":"11","key":"10.1016\/j.inpsyc.2026.100240_bib50","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1136\/jnnp-2018-317970","article-title":"Tau-induced focal neurotoxicity and network disruption related to apathy in Alzheimer\u2019s disease","volume":"89","author":"Kitamura","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.inpsyc.2026.100240_bib51","unstructured":"Marshall et al., \u2018Marshall et al., 2019\u2019. Accessed: Dec. 04, 2025. [Online]. Available: https:\/\/journals.sagepub.com\/doi\/10.3233\/JAD-170578."},{"issue":"12","key":"10.1016\/j.inpsyc.2026.100240_bib52","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.1093\/brain\/awaf194","article-title":"Mild behavioural impairment-apathy and core Alzheimer\u2019s disease cerebrospinal fluid biomarkers","volume":"148","author":"Vellone","year":"2025","journal-title":"Brain"},{"key":"10.1016\/j.inpsyc.2026.100240_bib53","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.neubiorev.2019.09.014","article-title":"Affective symptoms and AT(N) biomarkers in mild cognitive impairment and Alzheimer\u2019s disease: A systematic literature review","volume":"107","author":"Banning","year":"2019","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"10.1016\/j.inpsyc.2026.100240_bib54","first-page":"31","article-title":"Association between high-sensitivity C-reactive protein and risk of early idiopathic Parkinson\u2019s disease","volume":"32","author":"Song","year":"2011","journal-title":"Neurol Sci J Ital Neurol Soc Ital Soc Clin Neurophysiol"},{"key":"10.1016\/j.inpsyc.2026.100240_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.inpsyc.2025.100181","article-title":"Peripheral biomarkers associated with apathy and predicting response to methylphenidate: Secondary analysis of the Apathy in Dementia Methylphenidate Trial 2 (ADMET2) study","author":"Sankhe","year":"2026","journal-title":"Int Psychogeriatr"},{"issue":"2","key":"10.1016\/j.inpsyc.2026.100240_bib56","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3233\/JAD-230426","article-title":"The Effect of Apathy and Depressive Syndromes on Functional Outcomes in Alzheimer\u2019s Disease","volume":"98","author":"Njomboro","year":"2024","journal-title":"J Alzheimer\u2019S Dis"},{"issue":"7S_Part_14","key":"10.1016\/j.inpsyc.2026.100240_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.jalz.2017.06.919","article-title":"p2\u2013266]: Apathy Impairs Advanced Activities of Daily Living in Very Mild Alzheimer Disease","volume":"13","author":"Delgado","year":"2017","journal-title":"Alzheimers Dement"},{"issue":"3","key":"10.1016\/j.inpsyc.2026.100240_bib58","article-title":"Physical environmental designs in residential care to improve quality of life of older people","volume":"2022","author":"Harrison","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.inpsyc.2026.100240_bib59","doi-asserted-by":"crossref","first-page":"420","DOI":"10.62641\/aep.v52i4.1643","article-title":"Enhancing outcomes in Alzheimer\u2019s disease: exploring the effects of a diversified rehabilitation program combined with donepezil on apathy, cognitive function, and family caregiver burden","volume":"52","author":"Ji","year":"2024","journal-title":"Actas Esp Psiquiatr"},{"issue":"4","key":"10.1016\/j.inpsyc.2026.100240_bib60","doi-asserted-by":"crossref","DOI":"10.1177\/0891988718783897","article-title":"Neuropsychiatric symptoms and caregiver burden in individuals with Alzheimer\u2019s disease: the TEAM-AD VA cooperative study","volume":"31","author":"Chen","year":"2018","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"5","key":"10.1016\/j.inpsyc.2026.100240_bib61","article-title":"Behavioural and psychological symptoms in dementia and the challenges for family carers: systematic review","volume":"208","author":"Feast","year":"2016","journal-title":"Br J Psychiatry J"},{"issue":"2","key":"10.1016\/j.inpsyc.2026.100240_bib62","doi-asserted-by":"crossref","DOI":"10.1080\/13607863.2022.2032597","article-title":"Residential aged care staff perceptions and responses towards neuropsychiatric symptoms: a mixed methods analysis of electronic healthcare records","volume":"27","author":"Eikelboom","year":"2023","journal-title":"Aging Ment Health"},{"issue":"1","key":"10.1016\/j.inpsyc.2026.100240_bib63","doi-asserted-by":"crossref","DOI":"10.1186\/s12877-022-02922-x","article-title":"Family caregivers\u2019 perspectives on their interaction and relationship with people living with dementia in a nursing home: a qualitative study","volume":"22","author":"van Corven","year":"2022","journal-title":"BMC Geriatr"},{"issue":"5","key":"10.1016\/j.inpsyc.2026.100240_bib64","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/gps.490","article-title":"The cost of behavioral and psychological symptoms of dementia (BPSD) in community dwelling Alzheimer\u2019s disease patients","volume":"17","author":"Beeri","year":"2002","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.inpsyc.2026.100240_bib65","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.trci.2019.01.002","article-title":"Neuropsychiatric symptoms in patients with dementia and the longitudinal costs of informal care in the Cache County population","volume":"5","author":"Rattinger","year":"2019","journal-title":"\u2019 Alzheimers Dement N Y N"},{"issue":"2","key":"10.1016\/j.inpsyc.2026.100240_bib66","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2147\/ciia.2006.1.2.143","article-title":"Economic considerations in the management of Alzheimer\u2019s disease","volume":"1","author":"Zhu","year":"2006","journal-title":"Clin Interv Aging"},{"issue":"10","key":"10.1016\/j.inpsyc.2026.100240_bib67","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/gps.1594","article-title":"The contribution of neuropsychiatric symptoms to the cost of dementia care","volume":"21","author":"Herrmann","year":"2006","journal-title":"Int J Geriatr Psychiatry"},{"issue":"2","key":"10.1016\/j.inpsyc.2026.100240_bib68","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/WAD.0b013e318203f208","article-title":"Caregiver burden and neuropsychiatric symptoms in older adults with cognitive impairment: the Aging, Demographics, and Memory Study (ADAMS)","volume":"25","author":"Okura","year":"2011","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"7","key":"10.1016\/j.inpsyc.2026.100240_bib69","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1002\/alz.12915","article-title":"Apathy in patients with Alzheimer's disease is a cost-driving factor","volume":"19","author":"Kruse","year":"2023","journal-title":"Alzheimer's & Dement J Alzheimer's Assoc"},{"issue":"5","key":"10.1016\/j.inpsyc.2026.100240_bib70","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.6027","article-title":"Bupropion for the Treatment of Apathy in Alzheimer Disease: A Randomized Clinical Trial","volume":"3","author":"Maier","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"8","key":"10.1016\/j.inpsyc.2026.100240_bib71","doi-asserted-by":"crossref","DOI":"10.1017\/S1041610219000589","article-title":"Association between environmental stimulation and apathy in nursing home residents with dementia","volume":"31","author":"Jao","year":"2019","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.inpsyc.2026.100240_bib72","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD012197.pub2","article-title":"Pharmacological interventions for apathy in Alzheimer\u2019s disease","author":"Ruthirakuhan","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.inpsyc.2026.100240_bib73","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jagp.2021.06.016","article-title":"Apathy as a Treatment Target in Alzheimer\u2019s Disease: Implications for Clinical Trials","volume":"30","author":"Mortby","year":"2022","journal-title":"Am J Geriatr Psychiatry J Am Assoc Geriatr Psychiatry"},{"key":"10.1016\/j.inpsyc.2026.100240_bib74","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1146\/annurev-pharmtox-022423-014645","article-title":"Apathy and Motivation: Biological Basis and Drug Treatment","volume":"64","author":"Costello","year":"2024","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"7","key":"10.1016\/j.inpsyc.2026.100240_bib75","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/archpsyc.60.7.737","article-title":"Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS","volume":"60","author":"Lyketsos","year":"2003","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"10.1016\/j.inpsyc.2026.100240_bib76","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1600-0447.1992.tb03242.x","article-title":"A controlled multicenter clinical study of citalopram and placebo in elderly depressed patients with and without concomitant dementia","volume":"86","author":"Nyth","year":"1992","journal-title":"Acta Psychiatr Scand"},{"issue":"3","key":"10.1016\/j.inpsyc.2026.100240_bib77","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1176\/appi.ajp.159.3.460","article-title":"Comparison of citalopram, perphenazine, and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized, demented patients","volume":"159","author":"Pollock","year":"2002","journal-title":"Am J Psychiatry"},{"issue":"7","key":"10.1016\/j.inpsyc.2026.100240_bib78","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1001\/jama.2014.93","article-title":"Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial","volume":"311","author":"Porsteinsson","year":"2014","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.inpsyc.2026.100240_bib79","doi-asserted-by":"crossref","first-page":"915","DOI":"10.4088\/JCP.08m04828","article-title":"Effect of a serotonin reuptake inhibitor on irritability, apathy, and psychotic symptoms in patients with Alzheimer\u2019s disease","volume":"70","author":"Siddique","year":"2009","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"10.1016\/j.inpsyc.2026.100240_bib80","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/archpsyc.1987.01800170041007","article-title":"\u2018L-deprenyl in Alzheimer\u2019s disease. Preliminary evidence for behavioral change with monoamine oxidase B inhibition","volume":"44","author":"Tariot","year":"1987","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"10.1016\/j.inpsyc.2026.100240_bib81","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/gps.1032","article-title":"Olanzapine versus placebo in the treatment of psychosis with or without associated behavioral disturbances in patients with Alzheimer\u2019s disease","volume":"19","author":"De Deyn","year":"2004","journal-title":"Int J Geriatr Psychiatry"},{"issue":"9","key":"10.1016\/j.inpsyc.2026.100240_bib82","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/gps.1998","article-title":"Stopping antipsychotic drug therapy in demented nursing home patients: a randomized, placebo-controlled study--the Bergen District Nursing Home Study (BEDNURS)","volume":"23","author":"Ruths","year":"2008","journal-title":"Int J Geriatr Psychiatry"},{"issue":"7","key":"10.1016\/j.inpsyc.2026.100240_bib83","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1176\/appi.ajp.2008.07111779","article-title":"Clinical symptom responses to atypical antipsychotic medications in Alzheimer\u2019s disease: phase 1 outcomes from the CATIE-AD effectiveness trial","volume":"165","author":"Sultzer","year":"2008","journal-title":"Am J Psychiatry"},{"issue":"4","key":"10.1016\/j.inpsyc.2026.100240_bib84","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1212\/WNL.57.4.613","article-title":"A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer\u2019s disease","volume":"57","author":"Feldman","year":"2001","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.inpsyc.2026.100240_bib85","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1017\/S104161020200858X","article-title":"Efficacy of donepezil on behavioral symptoms in patients with moderate to severe Alzheimer\u2019s disease","volume":"14","author":"Gauthier","year":"2002","journal-title":"Int Psychogeriatr"},{"issue":"6","key":"10.1016\/j.inpsyc.2026.100240_bib86","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/00019442-200506000-00012","article-title":"Galantamine Treatment of Problematic Behavior in Alzheimer Disease: Post-Hoc Analysis of Pooled Data From Three Large Trials","volume":"13","author":"Herrmann","year":"2005","journal-title":"Am J Geriatr Psychiatry"},{"issue":"12","key":"10.1016\/j.inpsyc.2026.100240_bib87","first-page":"1590","article-title":"A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer\u2019s disease in the nursing home setting\u2019","volume":"49","author":"Tariot","year":"2001","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.inpsyc.2026.100240_bib88","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.parkreldis.2018.11.002","article-title":"Pharmacological treatment of apathy in Lewy body disorders: A systematic review","volume":"60","author":"Liu","year":"2019","journal-title":"Park Relat Disord"},{"issue":"1","key":"10.1016\/j.inpsyc.2026.100240_bib89","first-page":"89","article-title":"Improvement of apathy in early Parkinson\u2019s disease\u2019, NPJ","volume":"11","author":"Castrioto","year":"2025","journal-title":"Park Dis"},{"issue":"Pt 5","key":"10.1016\/j.inpsyc.2026.100240_bib90","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1093\/brain\/awt067","article-title":"Parkinsonian apathy responds to dopaminergic stimulation of D2\/D3 receptors with piribedil","volume":"136","author":"Thobois","year":"2013","journal-title":"Brain J Neurol"},{"key":"10.1016\/j.inpsyc.2026.100240_bib91","doi-asserted-by":"crossref","first-page":"796","DOI":"10.4088\/JCP.10m06708","article-title":"A randomized, double-blind, placebo-controlled trial of modafinil for the treatment of apathy in individuals with mild-to-moderate Alzheimer\u2019s disease","volume":"73","author":"Frakey","year":"2012","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"10.1016\/j.inpsyc.2026.100240_bib92","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1021\/acschemneuro.7b00374","article-title":"An Overview of the Clinical Uses, Pharmacology, and Safety of Modafinil","volume":"9","author":"Murillo-Rodr\u00edguez","year":"2018","journal-title":"ACS Chem Neurosci"},{"issue":"3","key":"10.1016\/j.inpsyc.2026.100240_bib93","first-page":"349","article-title":"Mechanisms of modafinil: A review of current research\u2019","volume":"3","author":"Gerrard","year":"2007","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.inpsyc.2026.100240_bib94","series-title":"Modafinil\u2019, in StatPearls, Treasure Island (FL)","author":"Greenblatt","year":"2025"},{"key":"10.1016\/j.inpsyc.2026.100240_bib95","series-title":"\u2018Methylphenidate\u2019, in StatPearls, Treasure Island (FL)","author":"Verghese","year":"2025"},{"issue":"2","key":"10.1016\/j.inpsyc.2026.100240_bib96","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1176\/appi.ajp.2017.17030316","article-title":"Methylphenidate for apathy in community-dwelling older veterans with mild Alzheimer\u2019s disease: a double-blind, randomized, placebo-controlled trial","volume":"175","author":"Padala","year":"2018","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.inpsyc.2026.100240_bib97","doi-asserted-by":"crossref","first-page":"810","DOI":"10.4088\/JCP.12m08099","article-title":"Safety and efficacy of methylphenidate for apathy in Alzheimer\u2019s disease: a randomized, placebo-controlled trial","volume":"74","author":"Rosenberg","year":"2013","journal-title":"J Clin Psychiatry"},{"issue":"11","key":"10.1016\/j.inpsyc.2026.100240_bib98","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1001\/jamaneurol.2021.3356","article-title":"Effect of methylphenidate on apathy in patients with Alzheimer disease: the ADMET 2 randomized clinical trial","volume":"78","author":"Mintzer","year":"2021","journal-title":"JAMA Neurol"},{"issue":"6","key":"10.1016\/j.inpsyc.2026.100240_bib99","doi-asserted-by":"crossref","DOI":"10.1002\/gps.6108","article-title":"Adverse effects of methylphenidate for apathy in patients with Alzheimer\u2019s disease (ADMET2 trial)","volume":"39","author":"Zeng","year":"2024","journal-title":"Int J Geriatr Psychiatry"},{"issue":"4","key":"10.1016\/j.inpsyc.2026.100240_bib100","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jagp.2019.07.014","article-title":"Recommendations for the Nonpharmacological Treatment of Apathy in Brain Disorders","volume":"28","author":"Manera","year":"2020","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.inpsyc.2026.100240_bib101","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.2147\/NDT.S483470","article-title":"Towards a Non-pharmacological Intervention on Apathy in Korsakoff\u2019s Syndrome: A Systematic Narrative Review Across Different Clinical Conditions","volume":"20","author":"Van Dorst","year":"2024","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"6","key":"10.1016\/j.inpsyc.2026.100240_bib102","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1177\/1533317516650806","article-title":"Ecopsychosocial interventions in cognitive decline and dementia: a new terminology and a new paradigm","volume":"31","author":"Zeisel","year":"2016","journal-title":"\u2019 Am J Alzheimers Dis Dement\u00ae"},{"issue":"4","key":"10.1016\/j.inpsyc.2026.100240_bib103","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/gps.5460","article-title":"The effectiveness of non-pharmacological interventions targeting neuropsychiatric symptoms among persons with preclinical and mild dementia: A systematic review and network meta-analysis","volume":"36","author":"Lin","year":"2021","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.inpsyc.2026.100240_bib104","unstructured":"Burns et al., \u2018A Clinician\u2019s BPSD Guide 2023: Understanding and helping people experiencing changed behaviours and psychological symptoms associated with dementia\u2019, 2023."},{"key":"10.1016\/j.inpsyc.2026.100240_bib105","article-title":"The effect of physical exercise on apathy in older adults: a systematic review and meta-analysis","volume":"13","author":"Jia","year":"2025","journal-title":"Front Public Health"},{"issue":"7","key":"10.1016\/j.inpsyc.2026.100240_bib106","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/JGP.0b013e31822be242","article-title":"Nonpharmacological management of apathy in dementia: a systematic review","volume":"20","author":"Brodaty","year":"2012","journal-title":"Am J Geriatr Psychiatry"},{"issue":"1","key":"10.1016\/j.inpsyc.2026.100240_bib107","article-title":"Efficacy of serious exergames in improving neuropsychiatric symptoms in neurocognitive disorders: Results of the X-TORP cluster randomized trial","volume":"7","author":"Robert","year":"2021","journal-title":"Alzheimers Dement (N Y"},{"issue":"2","key":"10.1016\/j.inpsyc.2026.100240_bib108","doi-asserted-by":"crossref","DOI":"10.2196\/35224","article-title":"Virtual Reality Intervention for Managing Apathy in People With Cognitive Impairment: Systematic Review","volume":"5","author":"Ho","year":"2022","journal-title":"JMIR Aging"},{"key":"10.1016\/j.inpsyc.2026.100240_bib109","doi-asserted-by":"crossref","DOI":"10.2196\/53348","article-title":"The effects of virtual reality\u2013based reminiscence therapies for older adults with cognitive impairment: systematic review","volume":"26","author":"Mao","year":"2024","journal-title":"J Med Internet Res"},{"key":"10.1016\/j.inpsyc.2026.100240_bib110","article-title":"Virtual reality-based reminiscence therapy for older adults to improve psychological well-being and cognition: A systematic review","author":"Ng","year":"2024","journal-title":"J Clin Nurs"},{"key":"10.1016\/j.inpsyc.2026.100240_bib111","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3389\/fnins.2017.00641","article-title":"Transcranial Direct Current Stimulation (tDCS): A Beginner\u2019s Guide for Design and Implementation","volume":"11","author":"Thair","year":"2017","journal-title":"Front Neurosci"},{"key":"10.1016\/j.inpsyc.2026.100240_bib112","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.neubiorev.2017.10.006","article-title":"Transcranial magnetic stimulation in basic and clinical neuroscience: A comprehensive review of fundamental principles and novel insights","volume":"83","author":"Valero-Cabr\u00e9","year":"2017","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.inpsyc.2026.100240_bib113","unstructured":"Wang et al., \u2018Comparison of multiple non-invasive neuromodulation strategies for depressive episodes in major depressive disorder and bipolar disorder: A systematic review and network meta-analysis of randomized controlled trials - Wang - 2026 - Psychiatry and Clinical Neurosciences - Wiley Online Library\u2019. Accessed: Feb. 24, 2026. [Online]. Available: https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/pcn.13918."},{"key":"10.1016\/j.inpsyc.2026.100240_bib114","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.pnpbp.2018.06.014","article-title":"Effectiveness of the prefrontal repetitive transcranial magnetic stimulation on cognitive profiles in depression, schizophrenia, and Alzheimer\u2019s disease: A systematic review","volume":"88","author":"Iimori","year":"2019","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.inpsyc.2026.100240_bib115","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1259481","article-title":"Repetitive transcranial magnetic stimulation for apathy in patients with neurodegenerative conditions, cognitive impairment, stroke, and traumatic brain injury: a systematic review","volume":"14","author":"Espiritu","year":"2023","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.inpsyc.2026.100240_bib116","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jpsychires.2024.01.016","article-title":"Efficacy and safety of neuromodulation for apathy in patients with Alzheimer\u2019s disease: A systematic review and meta-analysis of randomized controlled trials","volume":"171","author":"Jin","year":"2024","journal-title":"J Psychiatr Res"},{"issue":"6","key":"10.1016\/j.inpsyc.2026.100240_bib117","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.brs.2022.11.009","article-title":"Efficacy and safety of simultaneous rTMS-tDCS over bilateral angular gyrus on neuropsychiatric symptoms in patients with moderate Alzheimer\u2019s disease: A prospective, randomized, sham-controlled pilot study","volume":"15","author":"Hu","year":"2022","journal-title":"Brain Stimul"},{"issue":"8","key":"10.1016\/j.inpsyc.2026.100240_bib118","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006725","article-title":"rTMS of the left dorsolateral prefrontal cortex modulates dopamine release in the ipsilateral anterior cingulate cortex and orbitofrontal cortex","volume":"4","author":"Cho","year":"2009","journal-title":"PloS One"},{"issue":"15","key":"10.1016\/j.inpsyc.2026.100240_bib119","doi-asserted-by":"crossref","first-page":"RC157","DOI":"10.1523\/JNEUROSCI.21-15-j0003.2001","article-title":"Repetitive transcranial magnetic stimulation of the human prefrontal cortex induces dopamine release in the caudate nucleus","volume":"21","author":"Strafella","year":"2001","journal-title":"J Neurosci J Soc Neurosci"},{"key":"10.1016\/j.inpsyc.2026.100240_bib120","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/bs.pbr.2016.05.007","article-title":"The role of dopamine in the pathophysiology and treatment of apathy","volume":"229","author":"Chong","year":"2016","journal-title":"Prog Brain Res"},{"issue":"10","key":"10.1016\/j.inpsyc.2026.100240_bib121","doi-asserted-by":"crossref","DOI":"10.1080\/13607863.2021.2008309","article-title":"The struggle of apathy in dementia","volume":"26","author":"Dening","year":"2022","journal-title":"Aging Ment Health"},{"key":"10.1016\/j.inpsyc.2026.100240_bib122","doi-asserted-by":"crossref","DOI":"10.1111\/jgs.15343","article-title":"State of the Science: Apathy as a Model for Investigating Behavioral and Psychological Symptoms in Dementia","volume":"66","author":"Massimo","year":"2018","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.inpsyc.2026.100240_bib123","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jad.2015.09.069","article-title":"The prevalence of neuropsychiatric symptoms in Alzheimer\u2019s disease: Systematic review and meta-analysis","volume":"190","author":"Zhao","year":"2016","journal-title":"J Affect Disord"},{"issue":"3","key":"10.1016\/j.inpsyc.2026.100240_bib124","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2018-318265","article-title":"Brain mechanisms underlying apathy","volume":"90","author":"Le Heron","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.inpsyc.2026.100240_bib125","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/gps.4666","article-title":"Quality of Life in relation to neuropsychiatric symptoms in Alzheimer\u2019s disease: 5-year prospective ALSOVA cohort study","volume":"33","author":"Hongisto","year":"2018","journal-title":"Int J Geriatr Psychiatry"},{"issue":"10","key":"10.1016\/j.inpsyc.2026.100240_bib126","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1111\/jgs.15007","article-title":"Apathy: Risk Factor for Mortality in Nursing Home Patients","volume":"65","author":"Nijsten","year":"2017","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"10.1016\/j.inpsyc.2026.100240_bib127","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1177\/1471301214527300","article-title":"The relationship between apathy and participation in therapeutic activities in nursing home residents with dementia: Evidence for an association and directions for further research","volume":"15","author":"Ellis","year":"2016","journal-title":"\u2019 Dement Lond Engl"},{"issue":"7","key":"10.1016\/j.inpsyc.2026.100240_bib128","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jamda.2017.10.004","article-title":"Nursing staff distress associated with neuropsychiatric symptoms in young-onset dementia and late-onset dementia","volume":"19","author":"van Duinen-van den IJssel","year":"2018","journal-title":"J Am Med Dir Assoc"},{"issue":"2","key":"10.1016\/j.inpsyc.2026.100240_bib129","article-title":"Interventions promoting family involvement with care homes following placement of a relative with dementia: a systematic review","volume":"21","author":"Hayward","year":"2022","journal-title":"Dement Lond Engl"},{"issue":"8","key":"10.1016\/j.inpsyc.2026.100240_bib130","doi-asserted-by":"crossref","DOI":"10.1177\/0898264316660414","article-title":"A systematic review and meta-analysis comparing carer focused and dyadic multicomponent interventions for carers of people with dementia","volume":"29","author":"Laver","year":"2017","journal-title":"J Aging Health"},{"issue":"3","key":"10.1016\/j.inpsyc.2026.100240_bib131","article-title":"Influence of sense of competence, empathy and relationship quality on burden in dementia caregivers: a 15 months longitudinal study","volume":"42","author":"Kieboom","year":"2023","journal-title":"J Appl Gerontol J South Gerontol Soc"},{"issue":"3","key":"10.1016\/j.inpsyc.2026.100240_bib132","article-title":"Managing apathy among people with dementia living in institutional settings: staff\u2019s perceived gap between common and best practices","volume":"42","author":"Villar","year":"2021","journal-title":"Geriatr Nur (Lond )"},{"issue":"7","key":"10.1016\/j.inpsyc.2026.100240_bib133","doi-asserted-by":"crossref","DOI":"10.1002\/gps.5770","article-title":"Biweekly fluctuations of neuropsychiatric symptoms according to the Neuropsychiatric Inventory: erratic symptoms or scores?","volume":"37","author":"Eikelboom","year":"2022","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.inpsyc.2026.100240_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijnurstu.2021.104098","article-title":"Empowerment for people living with dementia: an integrative literature review","volume":"124","author":"van Corven","year":"2021","journal-title":"Int J Nurs Stud"},{"issue":"12","key":"10.1016\/j.inpsyc.2026.100240_bib135","doi-asserted-by":"crossref","DOI":"10.1017\/S1041610213001440","article-title":"More insight into the concept of apathy: a multidisciplinary depression management program has different effects on depressive symptoms and apathy in nursing homes","volume":"25","author":"Leontjevas","year":"2013","journal-title":"Int Psychogeriatr"},{"issue":"5","key":"10.1016\/j.inpsyc.2026.100240_bib136","doi-asserted-by":"crossref","DOI":"10.1016\/j.jamda.2024.03.007","article-title":"Guideline recommendations on behavioral and psychological symptoms of dementia: a systematic review","volume":"25","author":"Watt","year":"2024","journal-title":"J Am Med Dir Assoc"},{"issue":"2","key":"10.1016\/j.inpsyc.2026.100240_bib137","doi-asserted-by":"crossref","DOI":"10.1080\/13607863.2023.2228252","article-title":"The development and feasibility evaluation of a program to identify and manage apathy in people with dementia: the SABA program","volume":"28","author":"Nijsten","year":"2024","journal-title":"Aging Ment Health"},{"issue":"5","key":"10.1016\/j.inpsyc.2026.100240_bib138","article-title":"Use of the physical environment to support everyday activities for people with dementia: a systematic review","volume":"17","author":"Woodbridge","year":"2018","journal-title":"Dement Lond Engl"}],"container-title":["International Psychogeriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104161022600058X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104161022600058X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T20:17:25Z","timestamp":1784319445000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104161022600058X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":138,"alternative-id":["S104161022600058X"],"URL":"https:\/\/doi.org\/10.1016\/j.inpsyc.2026.100240","relation":{},"ISSN":["1041-6102"],"issn-type":[{"value":"1041-6102","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Apathy in persons with neurocognitive disorders: Moving the field forward","name":"articletitle","label":"Article Title"},{"value":"International Psychogeriatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.inpsyc.2026.100240","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of International Psychogeriatric Association.","name":"copyright","label":"Copyright"}],"article-number":"100240"}}